PS
NGM
Peter Svennilson’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $287M | Buy |
18,017,932
+310,954
| +2% | +$4.95M | 23.39% | 1 |
|
|
2020
Q2 | $350M | Buy |
17,706,978
+383,834
| +2% | +$7.58M | 29.23% | 1 |
|
|
2020
Q1 | $214M | Buy |
17,323,144
+902,315
| +5% | +$11.1M | 27.04% | 1 |
|
|
2019
Q4 | $304M | Buy |
16,420,829
+253,922
| +2% | +$4.7M | 36.26% | 1 |
|
|
2019
Q3 | $224M | Buy |
16,166,907
+472,816
| +3% | +$6.55M | 69.59% | 1 |
|
|
2019
Q2 | $230M | Buy |
+15,694,091
| New | +$230M | 65.66% | 1 |
|